XML 14 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Consolidated net loss $ (10,792) $ (14,881)
Other comprehensive loss:    
Change in unrealized loss on available-for-sale investments, net of tax (62) (26)
Comprehensive loss (10,854) (14,907)
Comprehensive loss attributable to noncontrolling interest in Pangu BioPharma Limited 1 1
Comprehensive loss attributable to aTyr Pharma, Inc. common stockholders $ (10,853) $ (14,906)